Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.

IF 3.4 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Ethnicity & Disease Pub Date : 2022-01-20 eCollection Date: 2022-01-01 DOI:10.18865/ed.32.1.61
Owen Garrick, Ruben Mesa, Andrea Ferris, Edward S Kim, Edith Mitchell, Otis W Brawley, John Carpten, Keith D Carter, Joseph Coney, Robert Winn, Stephanie Monroe, Fabian Sandoval, Edith Perez, Mitzi Williams, Evan Grove, Quita Highsmith, Nicole Richie, Susan M Begelman, Asha S Collins, Jamie Freedman, Melissa S Gonzales, Gerren Wilson
{"title":"Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.","authors":"Owen Garrick,&nbsp;Ruben Mesa,&nbsp;Andrea Ferris,&nbsp;Edward S Kim,&nbsp;Edith Mitchell,&nbsp;Otis W Brawley,&nbsp;John Carpten,&nbsp;Keith D Carter,&nbsp;Joseph Coney,&nbsp;Robert Winn,&nbsp;Stephanie Monroe,&nbsp;Fabian Sandoval,&nbsp;Edith Perez,&nbsp;Mitzi Williams,&nbsp;Evan Grove,&nbsp;Quita Highsmith,&nbsp;Nicole Richie,&nbsp;Susan M Begelman,&nbsp;Asha S Collins,&nbsp;Jamie Freedman,&nbsp;Melissa S Gonzales,&nbsp;Gerren Wilson","doi":"10.18865/ed.32.1.61","DOIUrl":null,"url":null,"abstract":"<p><p>Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.</p>","PeriodicalId":50495,"journal":{"name":"Ethnicity & Disease","volume":"32 1","pages":"61-68"},"PeriodicalIF":3.4000,"publicationDate":"2022-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785867/pdf/ethndis-32-61.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethnicity & Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18865/ed.32.1.61","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 5

Abstract

Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.

推进包容性研究:建立合作战略以提高临床试验的多样性。
临床研究中明显的差异对有色人种患者的影响不成比例,特别是在服务不足的社区。为了解决这些障碍,基因泰克成立了推进包容性研究外部理事会,这是一个由14人组成的委员会,致力于制定增加临床研究参与的战略。为了帮助改善有色人种患者的招募和保留,本文记录了我们在过去四年中在系统、研究和患者层面切实解决临床研究障碍的努力。这些努力是充分实现个性化医疗保健承诺的初步步骤之一,并以更低的社会成本为患者提供更多的好处。在这里,我们不是简单地承认这个问题,而是阐明了协作和多层次的策略,这些策略在为患者提供有意义的进展方面是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ethnicity & Disease
Ethnicity & Disease 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.30
自引率
0.00%
发文量
43
审稿时长
6-12 weeks
期刊介绍: Ethnicity & Disease is an international journal that exclusively publishes information on the causal and associative relationships in the etiology of common illnesses through the study of ethnic patterns of disease. Topics focus on: ethnic differentials in disease rates;impact of migration on health status; social and ethnic factors related to health care access and health; and metabolic epidemiology. A major priority of the journal is to provide a forum for exchange between the United States and the developing countries of Europe, Africa, Asia, and Latin America.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信